ANIP logo
ANI Pharmaceuticals, Inc.(ANIP)
Last print unknown agoAbout this dataData status
$72.56▲0.27 (0.37%)Stale · unknown old

ANIP R&D Expense Growth

15.89%Fiscal year

Period ending:

ANIP FY R&D Growth (YoY)%
ANIP FY R&D Growth (YoY)270.99%-128.53%
1998-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

ANIP r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 28 observations from Dec 31, 1998 to Dec 31, 2025.

Ani Pharmaceuticals Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
15.8879%
30.0268%
53.6249%
96.3057%
-28.9482%
-19.2114%
28.7107%
69.6582%
212.1129%
1.1134%
7.3189%
56.4252%
-89.8631%
-61.7746%
11.2749%
190.2327%
-13.3591%
232.3288%
23.2296%
-39.8407%
-30.0505%
148.2091%
-22.8836%
123.4801%
13.4605%
185.7805%
-52.8195%
0%

Compare r&d expense growth

All ANIP financial metrics · ANIP stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.